Cubist Systematic Strategies’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-111,512	Closed	-$125K	–	3329
2025 Q2	$125K	Buy	+111,512	New	+$130K	﹤0.01%	2682
2025 Q1	–	Sell	-7,776	Closed	-$12.8K	–	3193
2024 Q4	$12.8K	Buy	+7,776	New	+$19.6K	﹤0.01%	2853
2024 Q1	–	Sell	-214,345	Closed	-$802K	–	3965
2023 Q4	$802K	Buy	214,345 +179,543	+516%	+$424K	0.01%	2212
2023 Q3	$73.8K	Sell	34,802 -420,135	-92%	-$1.39M	﹤0.01%	2978
2023 Q2	$2.17M	Sell	454,937 -188,182	-29%	-$1.04M	0.02%	1424
2023 Q1	$3.67M	Buy	643,119 +70,570	+12%	+$426K	0.03%	1177
2022 Q4	$5.78M	Buy	572,549 +313,923	+121%	+$5.9M	0.05%	886
2022 Q3	$5.8M	Sell	258,626 -108,436	-30%	-$3.13M	0.04%	931
2022 Q2	$9.1M	Buy	367,062 +350,056	+2,058%	+$9.66M	0.07%	507
2022 Q1	$659K	Buy	17,006 +6,410	+60%	+$248K	0.01%	2354
2021 Q4	$620K	Sell	10,596 -70,438	-87%	-$3.99M	0.01%	2289
2021 Q3	$4.8M	Buy	81,034 +62,238	+331%	+$4.88M	0.06%	486
2021 Q2	$1.63M	Sell	18,796 -24,283	-56%	-$1.96M	0.02%	1229
2021 Q1	$3.55M	Sell	43,079 -28,281	-40%	-$2.71M	0.05%	640
2020 Q4	$6.49M	Sell	71,360 -15,112	-17%	-$938K	0.09%	320
2020 Q3	$3.46M	Buy	86,472 +86,372	+86,372%	+$3.02M	0.05%	584
2020 Q2	$3K	Buy	+100	New	+$2.98K	﹤0.01%	2356
2020 Q1	–	Sell	-44,217	Closed	-$865K	–	2241
2019 Q4	$865K	Buy	44,217 +44,212	+884,240%	+$702K	0.02%	1248
2019 Q3	$0	Sell	5 -4,943	-100%	-$94.8K	﹤0.01%	2278
2019 Q2	$100K	Buy	4,948 +2,086	+73%	+$37.6K	﹤0.01%	2233
2019 Q1	$50K	Sell	2,862 -18,403	-87%	-$290K	﹤0.01%	2103
2018 Q4	$273K	Buy	+21,265	New	+$296K	0.01%	1348

Other funds holding FATE